1. Home
  2. MCRB vs ATLO Comparison

MCRB vs ATLO Comparison

Compare MCRB & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCRB
    SELLHOLDBUYas of 2 days ago
  • ATLO
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • MCRB 2010
  • ATLO 1903
  • Country
  • MCRB United States
  • ATLO United States
  • Employees
  • MCRB N/A
  • ATLO N/A
  • Industry
  • MCRB Biotechnology: Pharmaceutical Preparations
  • ATLO Major Banks
  • Sector
  • MCRB Health Care
  • ATLO Finance
  • Exchange
  • MCRB Nasdaq
  • ATLO Nasdaq
  • Market Cap
  • MCRB 141.9M
  • ATLO 166.6M
  • IPO Year
  • MCRB 2015
  • ATLO N/A
  • Fundamental
  • Price
  • MCRB $0.72
  • ATLO $17.71
  • Analyst Decision
  • MCRB Hold
  • ATLO
  • Analyst Count
  • MCRB 5
  • ATLO 0
  • Target Price
  • MCRB $4.00
  • ATLO N/A
  • AVG Volume (30 Days)
  • MCRB 872.3K
  • ATLO 12.4K
  • Earning Date
  • MCRB 03-13-2025
  • ATLO 05-07-2025
  • Dividend Yield
  • MCRB N/A
  • ATLO 4.52%
  • EPS Growth
  • MCRB N/A
  • ATLO N/A
  • EPS
  • MCRB 0.00
  • ATLO 1.14
  • Revenue
  • MCRB N/A
  • ATLO $53,455,000.00
  • Revenue This Year
  • MCRB N/A
  • ATLO N/A
  • Revenue Next Year
  • MCRB N/A
  • ATLO N/A
  • P/E Ratio
  • MCRB $924.36
  • ATLO $15.58
  • Revenue Growth
  • MCRB N/A
  • ATLO 2.24
  • 52 Week Low
  • MCRB $0.54
  • ATLO $15.69
  • 52 Week High
  • MCRB $1.53
  • ATLO $22.03
  • Technical
  • Relative Strength Index (RSI)
  • MCRB 46.92
  • ATLO 42.98
  • Support Level
  • MCRB $0.69
  • ATLO $17.45
  • Resistance Level
  • MCRB $0.76
  • ATLO $17.99
  • Average True Range (ATR)
  • MCRB 0.05
  • ATLO 0.33
  • MACD
  • MCRB 0.00
  • ATLO -0.05
  • Stochastic Oscillator
  • MCRB 53.55
  • ATLO 25.00

Stock Price Comparison Chart: MCRB vs ATLO

MCRB
ATLO
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober202502468101214161820222426MCRB VS ATLO

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use